Serum and Plasma Copy Number Detection Using Real-time PCR.

about

Serum and Plasma Copy Number Detection Using Real-time PCR.

Item

http://www.wikidata.org/entity/Q48510469

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Serum and Plasma Copy Number Detection Using Real-time PCR.

@en

Serum and Plasma Copy Number Detection Using Real-time PCR.

@nl

type

Item

label

Serum and Plasma Copy Number Detection Using Real-time PCR.

@en

Serum and Plasma Copy Number Detection Using Real-time PCR.

@nl

prefLabel

Serum and Plasma Copy Number Detection Using Real-time PCR.

@en

Serum and Plasma Copy Number Detection Using Real-time PCR.

@nl

P1476

Serum and Plasma Copy Number Detection Using Real-time PCR.

@en

P2093

Daniele Calistri

http://www.w3.org/2001/XMLSchema#string

Filippo Martignano

http://www.w3.org/2001/XMLSchema#string

Valentina Casadio

http://www.w3.org/2001/XMLSchema#string

P2860

Cell-free DNA as a diagnostic marker for cancer: current insights

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

Analysis of circulating tumor DNA to monitor metastatic breast cancer

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma.

Circulating tumor DNA as a liquid biopsy for cancer.

Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone.

Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsies

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.

Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer.

P31

scholarly article

P356

10.3791/56502

http://www.w3.org/2001/XMLSchema#string

P433

130

http://www.w3.org/2001/XMLSchema#string

P50

Samanta Salvi

Vincenza Conteduca

G Gurioli

P577

2017-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29286483

http://www.w3.org/2001/XMLSchema#string

P932

5755563

http://www.w3.org/2001/XMLSchema#string